Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Teva Announces Exclusive Launch of Generic Axiron® in the United States

Saturday, August 19, 2017

Teva Pharmaceutical Industries Ltd today announced the launch of generic Axiron testosterone topical solution CIII mg mL in the US Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testoste...

Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis

Saturday, August 19, 2017

Medivir AB and Ascletis today announce that Ascletis has licensed the exclusive rights to develop manufacture and commercialize Medivirs nucleotide polymerase inhibitor for hepatitis C MIV Ascletis code ASC in Greater China Under the terms of the...

BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub

Friday, August 18, 2017

BlueRock Therapeutics which is developing cellbased therapies designed to alter the course of degenerative disease today announces the expansion of the companys presence in Toronto with a research development and manufacturing site in the MaRS Discov...

Hikma Announces New Licensing Agreement With Takeda

Friday, August 18, 2017

Hikma Pharmaceuticals PLC the multinational pharmaceutical group today announces that through its wholly owned subsidiary Hikma Pharmaceuticals LLC it has agreed to expand its licensing and distribution agreement with Takeda Pharmaceutical Company Li...

Fosun Pharma Selects Medidata’s Unified Platform for Clinical Development in China

Thursday, August 17, 2017

Medidata the leading global provider of cloudbased technology and data analytics for clinical research today announced an enterprise agreement with leading Chinese healthcare group Shanghai Fosun Pharmaceutical Group Co Ltds subsidiary Shanghai Fosun...

SillaJen Announces Collaboration with the National Cancer Institute for Development of Combination Therapy

Thursday, August 17, 2017

SillaJen Inc a clinicalstage biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer today announced that it has entered into a Cooperative Research and Development Agreement CRADA with the National Cancer In...

Shuttle Pharmaceuticals and POLA Pharma Inc. Agree to License U.S. Rights to Doranidazole

Wednesday, August 16, 2017

Shuttle Pharmaceuticals Inc USA and POLA Pharma Inc Japan announced agreement to license the US rights for doranidazole a hypoxic cell radiation sensitizer for clinical development in treating cancers in combination with stereotactic body radiation t...

Leidos and Biosortia Pharmaceuticals Execute Memorandum of Understanding

Wednesday, August 16, 2017

Leidos a FORTUNE science and technology company has signed a Memorandum of Understanding MOU with Biosortia Pharmaceuticals to explore creating a new business relationship with a focus on identifying and advancing immunooncology and other immunother...

China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor

Monday, August 14, 2017

A unit of Chinas Fosun Group and Shanghai Pharmaceuticals Holding Co SS are among bidders for a stake in US speciality drugmaker Arbor Pharmaceuticals LLC the companies said on Monday The bids come as Chinese companies face tightening scrutiny on...

Huaren Pharmaceutical to invest 10.2 mln yuan to set up medical technology JV in Jinan

Monday, August 14, 2017

Huaren Pharmaceutical Co Ltd Says co plans to invest million yuan to set up a Jinanbased medical technology joint venture with Shandong Novatech Information System Co Ltd partner Says the joint venture will be mainly engaged in RD production prom...